Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending dose study of TSP-101 in healthy Japanese male volunteers
jRCT2071250096Phase 1Completed
- Sponsor
- Tensegrity Pharma
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing TSP-101 arm with Placebo arm (2 arms). Primary endpoint: Incidence and severity of treatment-emergent adverse events and serious adverse events. Started Nov 2025; status: completed.
02
Drugs
TSP-101
Beyond the preview
Go deeper on jRCT2071250096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250096.